Aerie Pharmaceuticals (AERI) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free AERI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10, 2024 | finance.yahoo.comGlobal $20B+ Macular Degeneration Treatment Market Outlook, 2024-2029: AI Integration Paves the Way for Personalized CareFebruary 29, 2024 | uk.finance.yahoo.com20 Countries With Worst Vision ProblemsFebruary 21, 2024 | finance.yahoo.comParatus Sciences Appoints Theresa Heah, M.D., M.B.A. as Chief Executive OfficerJanuary 12, 2024 | msn.comJustin Timberlake is ready to Rock Your Body for one night only in Memphis, and for freeJanuary 10, 2024 | msn.comAlcon’s dry eye drug achieves primary endpoints in Phase III trialsJanuary 8, 2024 | finanznachrichten.deCurative Biotechnology, Inc.: Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of DirectorsJanuary 8, 2024 | markets.businessinsider.comCurative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of DirectorsDecember 15, 2023 | finance.yahoo.comGlaucoma Therapeutics Market Size Projected to Reach USD 13.5 billion by 2031, With 5.5% CAGR: Transparency Market Research, Inc.November 28, 2023 | finance.yahoo.comGlobal Over the Counter (OTC) Drugs Market Size to Grow USD 265 Billion by 2032 | CAGR of 5.0%November 25, 2023 | nypost.comAerie’s Black Friday Sale is here —Save 40% off sitewide for a limited timeNovember 23, 2023 | finance.yahoo.comNetarsudil for Fuchs Endothelial Corneal Dystrophy (FECD), 2019-2023 Emerging Drug Insights and Forecasts to 2032November 23, 2023 | finance.yahoo.comGlobal Glaucoma Treatment Market Size To Grow USD 10.5 Billion by 2032 | CAGR of 5.0%October 27, 2023 | finanznachrichten.deOpthea Limited: Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFOOctober 27, 2023 | markets.businessinsider.comOpthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFOOctober 23, 2023 | finance.yahoo.comRetinal Vein Occlusion Market to Exhibit Considerable Growth at a CAGR of ~6% During the Study Period (2019–2032) | DelveInsightSeptember 25, 2023 | uk.finance.yahoo.comRising Glaucoma Cases Forecast a Strong Optic Nerves Disorder Treatment MarketSeptember 13, 2023 | benzinga.comOptic Nerves Disorder Treatment Market Rises: North America Takes the HelmAugust 25, 2023 | time.comAerie Promo CodesAugust 24, 2023 | uk.finance.yahoo.comAngina Pectoris Drugs Global Market Report 2023August 24, 2023 | uk.finance.yahoo.comOcular Hypertension Treatment Global Market Report 2023July 18, 2023 | msn.comAlcon (ALC) Gains From Robust Contact Lense Sales, LaunchesJune 27, 2023 | finance.yahoo.comVillageMD Welcomes Richard Rubino as Chief Financial OfficerJune 22, 2023 | marketwatch.comThe Glaucoma Therapeutics market's size, share, and revenue will be thoroughly examined, with an anticipated CAGR of 13% increase from 2023 to 2030.June 22, 2023 | uk.finance.yahoo.comI-Mab Announces the Appointment of Raj Kannan as CEOJune 22, 2023 | markets.businessinsider.comI-Mab Names Raj Kannan CEO - Quick FactsJune 8, 2023 | uk.finance.yahoo.comOphthalmic Drugs Global Market Report 2023May 17, 2023 | msn.comAlcon (ALC) Vision Care Sales Robust, Margin Pressure PersistsMay 17, 2023 | marketwatch.comGlaucoma Therapeutics Market Size and Growth Analysis 2023-2031 by Absolute Reports with [121 Pages] in Pharmaceuticals SectorMay 17, 2023 | marketwatch.comOptic Nerves Disorder Treatment Market Size Fundamentals And Forecast Analysis 2023-2030May 16, 2023 | marketwatch.comOphthalmology Therapeutics Market 2023: Global Opportunity Analysis by Revenue, Gross Margin, Market ShareMay 5, 2023 | marketwatch.com2030 Vision: Ophthalmology Drugs Market Value to Hit New HeightsMay 5, 2023 | marketwatch.comAnophthalmia and Microphthalmia Treatment Market Share, Size and Value Analysis with growing 5.3% CAGR during period 2023 to 2030May 4, 2023 | marketwatch.comGlaucoma Therapeutics Market Trend Analysis, Future Demand, Updates (2023-2030)May 4, 2023 | marketwatch.comRho Kinases Inhibitor Market 2023 Precise Outlook – Kowa Pharmaceuticals, Senju Pharmaceutical, Novartis AG, AERIE PHARMACEUTICALSMay 2, 2023 | uk.news.yahoo.comMindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing StrategyMay 2, 2023 | marketwatch.comGlaucoma Treatment Market Upcoming Trends, Size, Key Players, Revenue, Share, and Forecast 2023 to 2031April 28, 2023 | marketwatch.comWave-Front Aberrometer Market Research 2023 Growth, Trends, Outlook and Future Scope Analysis 2031April 27, 2023 | marketwatch.comGlaucoma and Dry Eye Diseases Market Research Analysis 2023-2031April 27, 2023 | marketwatch.com2023 to 2030, Rho Associated Protein Kinase 2 Market DemandApril 26, 2023 | thestreet.comAerie Pharma Falls on Glaucoma Eye Drop Safety ConcernsApril 20, 2023 | finance.yahoo.comCAGR of 7.7% | Global Fuchs Endothelial Corneal Dystrophy Market Size To Grow USD 360 Billion By 2032April 14, 2023 | finance.yahoo.comGlobal Glaucoma Therapeutics Market to Reach $7.2 Billion by 2030April 13, 2023 | marketwatch.comOphthalmology Therapeutics Market Data Source, And Forecast 2030April 7, 2023 | marketwatch.com2023 Rho Associated Protein Kinase 2 Market Share and Latest Growth Demand Status: Trends Analysis and Industry Expansion StrategiesApril 5, 2023 | marketwatch.comRho Associated Protein Kinase 2 Market Growth Predictions and Forecast 2030March 28, 2023 | marketwatch.comROCK2 Inhibitor Market 2023-2028: Future UpdatesMarch 27, 2023 | marketwatch.comGlobal Nystagmus Market Size by Application (Hospitals & Clinics, Research Centers) Forecast from 2023 to 2028March 27, 2023 | marketwatch.comRho-kinase Inhibitor Drugs Market Hitting New Highs by 2029 | Kowa Pharmaceuticals, Senju Pharmaceutical, NovartisMarch 27, 2023 | marketwatch.comRho Associated Protein Kinase 2 Market by 2031March 21, 2023 | marketwatch.comOphthalmic Therapeutic Drugs Market Statistics [2023-2028]: Emerging Trends and Future Growth Scenario Get Aerie Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter. Email Address This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. AERI Media Mentions By Week AERI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AERI News Sentiment▼0.000.77▲Average Medical News Sentiment AERI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AERI Articles This Week▼00▲AERI Articles Average Week Get Aerie Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MGTX News Today STRO News Today AGEN News Today DTIL News Today FRLN News Today APGE News Today IOVA News Today ACLX News Today DNLI News Today TWST News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AERI) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeBiden replacement revealed?Paradigm PressThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerie Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
